U.S. Markets closed

BioLife Solutions, Inc. (BLFS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
52.00+0.29 (+0.56%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close51.71
Bid48.50 x 800
Ask54.18 x 800
Day's Range49.84 - 52.22
52 Week Range28.15 - 60.67
Avg. Volume366,652
Market Cap1.753B
Beta (5Y Monthly)1.49
PE Ratio (TTM)N/A
EPS (TTM)-0.04
Earnings DateNov 03, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est62.14
  • Benzinga

    COO Of Biolife Solutions Makes $1.1M Sale

    De De, COO at Biolife Solutions (NASDAQ:BLFS), made a large insider sell on November 18, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that De sold 21,000 shares of Biolife Solutions at prices ranging from $50.75 to $51.39. The total transaction amounted to $1,072,540. Following the transaction, De still owns 103,333 shares of Biolife Solutions worth $5,390,882.00. Biolife Solutions shares are trading up 0.33% at

  • Benzinga

    Notable Biolife Solutions Insider Trades $1.0M In Company Stock

    Aby J Mathew, Insider at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on November 17, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Aby J Mathew exercised options to purchase 20,000 Biolife Solutions shares at a price of $1.64 per share for a total of $32,800 on November 17. They then sold their shares on multiple transactions in the open market. They sold at prices ranging from $48.11 to

  • PR Newswire

    BioLife Solutions Ranks 353 Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500™

    BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced it has ranked 353 in the 27th annual Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America. BioLife Solutions annual revenue grew 336% from 2017 to 2020, driven by organic growth and